AUG 17, 2026 · JOURNAL ARTICLE
Metabolomics‐Driven Bioactivity‐Guided Isolation and Molecular Docking Reveal Antibreast Cancer Metabolome Heterogeneity in Polygonum spp
Biomedical Chromatography
Early-stage natural product discovery using in vitro and mouse xenograft models with molecular docking; results are promising but preclinical and lack human data or regulatory validation.
Reported
Total metabolites identified209
Flavonoid compounds45
IC50 (PB-EA, 4T1 cells)23.28 ± 0.90 μg/mL